|Articles|August 18, 2022
An Innovative Excipient-Enhanced Growth Formulation for Treatment of Lung Cancer
Author(s)Lonza
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Trends Transitioning from 2025 into 2026
2
The Benefits of an Immune-Directed ADC Strategy
3
Amgen Acquires UK Biotech Dark Blue Therapeutics
4
Personalized Medicine vs. Precision Medicine
5